HIV Medicines
Estimated value
—
Awarded value
—
Suppliers
15
Lots
2
Published
07 May 2026
Description
Supply of HIV Medicines to NHS Scotland
Scope
- Reference
- NP43326
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 2 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Generic HIV Medicines | £6.5m | cancelled |
| 2 | Branded HIV Medicines | £83.2m | cancelled |
Award 1· 10 suppliers
Awarded —
Award 2· 5 suppliers
Awarded —
Total lots
2
Awarded
2
Estimated total
£89.7m
Awarded total
—
Generic HIV Medicines
Start
—
End
—
Estimated
£6.5m
CPV
Branded HIV Medicines
Start
—
End
—
Estimated
£83.2m
CPV
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Amarox Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 06 Jul 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 30 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |
| NHS National Framework for Generics Housekeeping | contract | — | 22 Dec 2025 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |